John M. Evans - 31 Mar 2025 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: CEO, Director
Signature: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol: BEAM
Transactions as of: 31 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 02 Apr 2025, 19:10:30 UTC
Previous filing: 02 Apr 2025
Next filing: 03 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAM	Common Stock	Award	$0	+77.5K	+8.26%	$0.00	1.02M	31 Mar 2025	Direct	F1
holding	BEAM	Common Stock						103K	31 Mar 2025	By John M. Evans, III 2018 Irrevocable Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.

Content

Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.